Postnatal Steroids in Preterm Infants: A Narrative Review Series—Part 3: Impacts on Growth, Neurodevelopment & Nutrition
1
Issued Date
2026-04-01
Resource Type
eISSN
22279067
Scopus ID
2-s2.0-105037221928
Journal Title
Children
Volume
13
Issue
4
Rights Holder(s)
SCOPUS
Bibliographic Citation
Children Vol.13 No.4 (2026)
Suggested Citation
Plessas-Azurduy P., Garfinkle J., Beltempo M., Porraccio C., Lapointe A., Wazneh L., Wutthigate P., Spénard S., Sbrocchi A.M., Racine M.B., Mawad W., Cavallé-Garrido T., Shalish W., Sant’Anna G., Altit G. Postnatal Steroids in Preterm Infants: A Narrative Review Series—Part 3: Impacts on Growth, Neurodevelopment & Nutrition. Children Vol.13 No.4 (2026). doi:10.3390/children13040475 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/116547
Title
Postnatal Steroids in Preterm Infants: A Narrative Review Series—Part 3: Impacts on Growth, Neurodevelopment & Nutrition
Corresponding Author(s)
Other Contributor(s)
Abstract
Background: Postnatal corticosteroids (CS) improve respiratory outcomes in preterm infants, but effects on growth and neurodevelopment remain incompletely understood. Methods: This third instalment of a narrative review series builds on physiologic principles to examine systemic CS consequences. Main Findings: We explore the interplay between growth restriction, hypoxia, and neurodevelopmental vulnerability, discussing brain imaging, metabolic disruptions, and HPA axis suppression. Conclusion: This review advocates for a holistic, physiology-informed approach to optimize outcomes by integrating nutritional vulnerability with cardiorespiratory status.